Documenti fondamentali

Visualizza tutta la documentazione

Vai a

1724088

USP

Zanamivir

Name: Zanamivir
Brand: USP
Price: 553 EUR

United States Pharmacopeia (USP) Reference Standard

Sinonimo/i:

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid, 4-Guanidino-Neu5Ac2en

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione

Taglio della confezione	SKU	Disponibilità	Prezzo
200 mg		Per informazioni sulla disponibilità, contatta il Servizio Clienti.	553,00 €

Informazioni su questo articolo

Formula empirica (notazione di Hill):

C₁₂H₂₀N₄O₇

Numero CAS:

139110-80-8

Peso molecolare:

332.31

NACRES:

NA.24

PubChem Substance ID:

329751520

UNSPSC Code:

41116107

MDL number:

MFCD00866966

553,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.

Richiedi un ordine in blocco

Servizio Tecnico

Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.

Permettici di aiutarti

Proprietà

grade

pharmaceutical primary standard

agency

USP

API family

zanamivir

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

CC(=O)N[C@@H]1[C@@H](NC(N)=N)C=C(O[C@H]1[C@H](O)[C@H](O)CO)C(O)=O

InChI

1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1

InChI key

ARAIBEBZBOPLMB-UFGQHTETSA-N

Descrizione

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Zanamivir USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Biochem/physiol Actions

Zanamivir is an influenza viral neuraminidase inhibitor.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo	Y0001702	SML0492	Y0001708
USP 1724088 Zanamivir	Y0001702 Zanamivir for assay	Sigma-Aldrich SML0492 Zanamivir	Y0001708 Zanamivir for system suitability
manufacturer/tradename USP	manufacturer/tradename EDQM	manufacturer/tradename -	manufacturer/tradename EDQM
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade -	grade pharmaceutical primary standard
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) -	application(s) pharmaceutical (small molecule)
format neat	format neat	format -	format neat
API family zanamivir	API family zanamivir	API family -	API family zanamivir
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. room temp	storage temp. 2-8°C

Still not finding the right product?

Explore all of our products under Zanamivir

pictograms

GHS07

signalword

Warning

hcodes

H302,H315,H319,H335

pcodes

P301 + P312 + P330 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Classe di stoccaggio

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey.

Ken Watanabe et al.

Archives of medical research, 45(5), 359-365 (2014-06-01)

Influenza viruses are a serious threat to human health and cause thousands of deaths annually. Thus, there is an urgent requirement for the development of novel anti-influenza virus drugs. Therefore, the aim of this study was to evaluate the anti-influenza

Enhanced human receptor binding by H5 haemagglutinins.

Xiaoli Xiong et al.

Virology, 456-457, 179-187 (2014-06-04)

Mutant H5N1 influenza viruses have been isolated from humans that have increased human receptor avidity. We have compared the receptor binding properties of these mutants with those of wild-type viruses, and determined the structures of their haemagglutinins in complex with

Influenza A virus infection in zebrafish recapitulates mammalian infection and sensitivity to anti-influenza drug treatment.

Kristin A Gabor et al.

Disease models & mechanisms, 7(11), 1227-1237 (2014-09-06)

Seasonal influenza virus infections cause annual epidemics and sporadic pandemics. These present a global health concern, resulting in substantial morbidity, mortality and economic burdens. Prevention and treatment of influenza illness is difficult due to the high mutation rate of the

Visualizza tutti i documenti correlati

Numero articolo commerciale globale

SKU	GTIN
1724088-200MG	04061833020593

Domande

Recensioni

Nessuna valutazione